Bayer’s quarterly core profit rose 5 percent as strong sales of its weed and fungus killers and cancer drugs more than offset weaker plastics earnings.
Bayer’s quarterly core profit rose 5 percent as strong sales of its weed and fungus killers and cancer drugs more than offset weaker plastics earnings.